| Date Filed | Type | Description |
| 07/01/2011 |
BW
| XenoPort Announces New Employment Inducement Award |
| 05/04/2011 |
BW
| XenoPort Reports First Quarter Financial Results |
| 04/27/2011 |
BW
| XenoPort to Release First Quarter Financial Results on May 4, 2011 |
| 04/25/2011 |
BW
| XenoPort Announces FDA Agreement on a Special Protocol Assessment for a Pivotal Phase 3 Clinical Trial of Arbaclofen Placarbil for Spasticity in MS Patients |
| 04/18/2011 |
MW
| XenoPort and Zalicus Poised for Growth as Earnings Trends Improve |
| 04/13/2011 |
BW
| XenoPort Announces Presentation of Preclinical Data for Novel Fumarate Analog XP23829 at the 63rd Annual Meeting of the American Academy of Neurology |
| 03/21/2011 |
BW
| XenoPort Reports Results from a Phase 2b Clinical Trial of Arbaclofen Placarbil as Adjunctive Treatment for Patients with GERD |
| 02/23/2011 |
BW
| XenoPort to Present at Upcoming Healthcare Conferences |
| 02/16/2011 |
BW
| XenoPort Reports Fourth Quarter and Year-End 2010 Financial Results |
| 12/09/2010 |
BW
| XenoPort Announces Pricing of Public Offering of Common Stock |
| 11/23/2010 |
BW
| XenoPort Awarded Grant from The Michael J. Fox Foundation |
| 11/08/2010 |
BW
| XenoPort Reports Third Quarter Financial Results |
| 11/05/2010 |
BW
| XenoPort Announces New Employment Inducement Award |
| 11/05/2010 |
BW
| XenoPort to Present at Upcoming Healthcare Conferences |
| 11/01/2010 |
BW
| XenoPort to Release Third Quarter Financial Results on November 8, 2010 |
| 10/13/2010 |
BW
| XenoPort Announces Presentation of Preclinical Data for Novel Fumarate Analog XP23829 at ECTRIMS |
| 10/01/2010 |
BW
| XenoPort Announces New Employment Inducement Awards |
| 09/28/2010 |
BW
| XenoPort Announces Presentation of New Data for XP21279 at World Parkinson Congress |
| 09/24/2010 |
BW
| Harwood Feffer LLP Files Class Action On Behalf Of Purchasers Of XenoPort, Inc. Securities For The Enlarged Class Period March 16, 2009 Through February 17, 2010 |
| 09/13/2010 |
BW
| XenoPort Announces Plans for Phase 3 Development of Arbaclofen Placarbil for Spasticity |
| 09/10/2010 |
BW
| Kahn Swick & Foti, LLC and Former Louisiana Attorney General Notify XenoPort Shareholders With Large Financial Interests of Securities Fraud Class Action - XNPT |
| 09/03/2010 |
BW
| CORRECTING and REPLACING XenoPort Announces New Employment Inducement Award |
| 08/26/2010 |
BW
| XenoPort Announces Changes to Executive Team |
| 08/12/2010 |
MW
| Brower Piven Encourages Investors Who Have Losses in Excess of $250,000 From Investment in XenoPort, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the September 27, 2010 Lead Plaintiff Deadline |
| 07/30/2010 |
MW
| Dyer & Berens LLP Files Class Action Lawsuit on Behalf of Investors Who Purchased the Common Stock of XenoPort, Inc. -- XNPT |
| 07/30/2010 |
MW
| Kahn Swick & Foti, LLC and Former Louisiana Attorney General Notify XenoPort Shareholders of Class Action Securities Fraud on Behalf of XNPT Shareholders From May 5, 2009 to February 17, 2010 - XNPT |
| 07/30/2010 |
BW
| Kendall Law Group Begins Investigation on Behalf of XenoPort, Inc. Shareholders |
| 07/29/2010 |
BW
| Bernstein Liebhard LLP Announces Filing of Action on Behalf of Investors in XenoPort, Inc. |
| 07/28/2010 |
MW
| Izard Nobel LLP Announces Class Action Lawsuit Against XenoPort, Inc. |
| 07/27/2010 |
BW
| XenoPort to Release Second Quarter Financial Results on August 5, 2010 |
| 07/26/2010 |
BW
| XenoPort to Present at the Wedbush Life Sciences Conference |
| 07/23/2010 |
BW
| XenoPort Announces Presentation of Preclinical Data for Acamprosate Prodrug at Fragile X Syndrome Conference |
| 07/02/2010 |
BW
| XenoPort Announces New Employment Inducement Awards |
| 05/18/2010 |
BW
| XenoPort to Present at the 2010 Citi Health Care Conference |
|